Close Menu

Morphosys

Daiichi Sankyo is the first collaborator to use Morphosys' HuCAL Platinum antibody library for new drug discovery in infectious diseases.

MorphoSys will fund research activities at the University of Melbourne in multiple new indications for the MOR103 antibody, which the company is developing as a rheumatoid arthritis treatment.

Pages

A new analysis suggests warming, not the arrival of humans, led to the extinction of the woolly rhinoceros thousands of years ago, the Economist reports.

Chinese health officials uncovered SARS-CoV-2 viral RNA on imported frozen food, but the New York Times reports catching COVID-19 that way would be unlikely.

The UK has ordered 60 million coronavirus vaccine doses from Novavax and 30 million doses from Janssen, according to the Guardian.

In Science this week: machine learning model predicts whether ion channel mutations will cause disease, and more.